ClinicalTrials.Veeva

Menu

Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy

A

Asan Medical Center

Status

Unknown

Conditions

Prostatic Neoplasms, Prostatectomy

Treatments

Drug: tamsulosin 0.4mg
Other: No medication

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01209988
AMC_UR_010

Details and patient eligibility

About

To date, there is a lack of consensus concerning the optimal timing for removal of the urethral catheter, its related complications, the effectiveness in prophylactic drug use to reduce complication, and the patient reported outcomes (quality of life) after robot-assisted laparoscopic prostatectomy (RALP). The purpose of this study is to determine the impact of tamsulosin on voiding patterns following early urethral catheter removal after RALP for prostate cancer.

Enrollment

220 estimated patients

Sex

Male

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must have localized or locally advanced prostate cancer
  • Patients must receive robot assisted laparoscopic radical prostatectomy
  • Patients must be able to provide written informed consent

Exclusion criteria

  • Patients must not have a history of treatment with alpha blockers within 4 weeks
  • Patients must not have previously undergone transurethral resection, laser therapy, or other surgery of the prostate
  • Patients must not have previously been diagnosed with neurogenic bladder
  • Patients must not have hypersensitivity to trial drug or other alpha-blockers
  • Patients must not have the participation of other clinical trial within the past 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

220 participants in 2 patient groups, including a placebo group

Tamsulosin 0.4mg
Experimental group
Description:
Perioperative tamsulosin 0.4mg daily
Treatment:
Drug: tamsulosin 0.4mg
Control
Placebo Comparator group
Description:
No medication
Treatment:
Other: No medication

Trial contacts and locations

1

Loading...

Central trial contact

Choung-Soo Kim, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems